| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.14 | 0.4 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.23 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |